doi.org/10.1016/s1470-2045(20)30109-1

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

..., Adrian Murphy
22
The Lancet Oncology35.90
Volume: 21, Issue: 5, Pages: 671 - 684
Published: Mar 20, 2020
Paper Fields
Paper Details
Title
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
DOI
doi.org/10.1016/s1470-2045(20)30109-1
Published Date
Mar 20, 2020
Journal
The Lancet Oncology
Volume
21
Issue
5
Pages
671 - 684
© 2026 Pluto Labs All rights reserved.